Newsroom

DUBLIN--(BUSINESS WIRE)--The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Plant Breeding and CRISPR Plants was valued at US$21.7 Billion in 2024 and is projected to reach US$50.1 Billion by 2030, growing at a CAGR of 15% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report incl...

RIYADH, Saudi Arabia--(BUSINESS WIRE)--Saudi Arabia’s EIF and Legends Global Score Big Joint Venture Announcement...

BEIJING & SHANGHAI & HONG KONG--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful listing on the Shanghai Stock Exchange STAR Market. This follows the Company’s listing on the Hong Kong Stock Exchange in September 2022 and marks a significant milestone in establishing Biocytogen as the first “H+A” dual-listed global drug innovator, reinforcin...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge Savings Bank (CSB) today announced that W. Calvin “Cal” Navatto has joined the Bank as Senior Vice President, Senior Asset-Based Lending (ABL) Relationship Manager within its Commercial Division. In this role, Navatto will focus on expanding CSB’s asset-based lending portfolio, deepening relationships with middle-market companies, and supporting the continued growth of the Bank’s ABL business. Navatto brings decades of experience in commercial financ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nick Gennari brings three decades of supply-chain and regulated material management leadership to GXP-Storage's Board of Directors....

ATLANTA--(BUSINESS WIRE)--Mercedes-Benz USA (MBUSA) is proud to announce the annual "Holidays with Love" campaign, featuring donations of all-electric Mercedes-Benz eSprinter vans to organizations across the country. This year’s “12 Days of Christmas” initiative brings together 12 Mercedes-Benz brand ambassadors, who will give the gift of sustainable, reliable transportation to deserving organizations making a difference in their communities. “Mercedes-Benz USA is proud to celebrate this holida...

ZUG, Suíça--(BUSINESS WIRE)--A Polpharma Biologics, empresa biofarmacêutica líder especializada no desenvolvimento e fabricação de biossimilares, tem o prazer de anunciar a assinatura de um acordo de licenciamento histórico com a empresa brasileira Libbs Farmacêutica! Por meio dessa parceria estratégica, a Libbs Farmacêutica obterá direitos exclusivos para comercializar um biossimilar de ponta para doenças autoimunes no mercado brasileiro, que está em rápido crescimento. A Polpharma Biologics m...

ZUG, Zwitserland--(BUSINESS WIRE)--Polpharma Biologics, een toonaangevend biofarmaceuticabedrijf gespecialiseerd in de ontwikkeling en productie van biosimilars, kondigt met genoegen de ondertekening aan van een belangrijke licentieovereenkomst met het Braziliaanse bedrijf Libbs Farmacêutica. Via dit strategische partnerschap verwerft Libbs Farmacêutica exclusieve rechten om een baanbrekende biosimilar voor auto-immuunziekten te commercialiseren in de snel groeiende Braziliaanse markt. Polpharm...

ZUG、スイス--(BUSINESS WIRE)--（ビジネスワイヤ） -- バイオシミラーの開発および製造を専門とする大手バイオ医薬品企業である Polpharma Biologics は、ブラジルの企業 Libbs Farmacêutica と画期的なライセンス契約を締結したことを大変喜ばしく発表します。この戦略的パートナーシップを通じて、Libbs Farmacêutica は急成長するブラジル市場において、自己免疫疾患向けの最先端バイオシミラーを独占的に販売する権利を取得します。 Polpharma Biologics は、バイオシミラーの開発および製造に関する全責任を引き続き負います。Libbs Farmacêutica は、ブラジルにおけるバイオシミラーの商業化、マーケティング、および流通に関する独占的ライセンスを保有します。この協業は、新たなエキサイティングな機会を切り開くものであり、両社が革新的でアクセスしやすい治療を患者に届けるという共通のコミットメントを示しています。 「バイオシミラーでブラジル市場に参入することは、Polpharma Biologics にとって...

CHICAGO--(BUSINESS WIRE)--FinFit Life, a mission-driven organization committed to helping individuals live Longer, Healthier, Better lives, proudly announces a new sponsorship partnership with Project Fire Buddies, a nonprofit dedicated to bringing joy, support, and encouragement to children battling critical illnesses. This collaboration marks a meaningful step in FinFit Life’s ongoing commitment to community health, family well-being, and service-driven impact. A Partnership Built on Purpose...